CLAIM CARDS
Claim Cards
Atomic claims extracted from accepted Researka artifacts, with source support, contradiction state, and provenance links when available.
Filtered to publication 556ed33d-b232-4c19-a24c-849a8c2d81a6
exploratory
The direct receipts support a narrow working claim: Supplementation was associated with reduced risk of MI (relative risk [RR], 0.87; 95% CI, 0.80 to 0.96), high certainty NNT of 272; but not CVD events (RR, 0.95; 95% CI, 0.90 to 1.00). The context receipts provide source breadth and boundary checks, not independent confirmation of the lead claim.
Contradiction: none
Sources: 5
exploratoryInterpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.
Contradiction: none
Sources: 5
exploratoryReal tension: the useful signal is narrower than the topic label. The lead receipts support the core claim, while the added A/B context receipts define where that claim may generalize, fail, or need a separate extraction.
Contradiction: none
Sources: 5
exploratory`fact_id=140174` (`A_core`) — Supplementation was associated with reduced risk of MI (relative risk [RR], 0.87; 95% CI, 0.80 to 0.96), high certainty NNT of 272 doi=10.1016/j.mayocp.2020.08.034
Contradiction: none
Sources: 5
exploratory`fact_id=1138` (`A_core`) — little or no effect of increasing LCn3 on all-cause mortality (risk ratio (RR) 0.97, 95% CI 0.93 to 1.01 doi=10.1002/14651858.cd003177.pub5
Contradiction: none
Sources: 5
exploratory`fact_id=178493` (`A_core`) — the 3 treatments combined showed a significant 39% decreased odds of becoming prefrail compared to the control doi=10.1093/gerona/glad073
Contradiction: none
Sources: 5
exploratory_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._
Contradiction: none
Sources: 5
exploratory`fact_id=1138` (`A_core`) — little or no effect of increasing LCn3 on all-cause mortality (risk ratio (RR) 0.97, 95% CI 0.93 to 1.01 Source: Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Contradiction: none
Sources: 5